Skyhawk Therapeutics’ investigational oral treatment SKY-0515 showed a 1.59-point difference [...]
Skyhawk Therapeutics has reported encouraging 12-month results from its ongoing [...]
Skyhawk Therapeutics’ investigational oral treatment SKY-0515 showed a 1.59-point difference [...]
Skyhawk Therapeutics has reported encouraging 12-month results from its ongoing [...]